Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Shares Issued (2016 - 2023)

Marimed (MRMD) has disclosed Shares Issued for 7 consecutive years, with $74000.0 as the latest value for Q3 2023.

  • Quarterly Shares Issued changed N/A to $74000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $74000.0 through Dec 2024, down 32.11% year-over-year, with the annual reading at $109000.0 for FY2023, 990.0% up from the prior year.
  • Shares Issued for Q3 2023 was $74000.0 at Marimed, up from $35000.0 in the prior quarter.
  • The five-year high for Shares Issued was $2.6 million in Q1 2019, with the low at -$2.6 million in Q2 2019.
  • Average Shares Issued over 4 years is $24222.1, with a median of $8000.0 recorded in 2021.
  • Peak annual rise in Shares Issued hit 333.33% in 2019, while the deepest fall reached 132.91% in 2019.
  • Over 4 years, Shares Issued stood at -$1.0 in 2019, then skyrocketed by 8400100.0% to $84000.0 in 2021, then plummeted by 96.43% to $3000.0 in 2022, then skyrocketed by 2366.67% to $74000.0 in 2023.
  • According to Business Quant data, Shares Issued over the past three periods came in at $74000.0, $35000.0, and $3000.0 for Q3 2023, Q2 2023, and Q1 2022 respectively.